Bookmark and Share
BioAssay: AID 743219

qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary

Oxidative stress has been implicated in the pathogenesis of a variety of diseases ranging from cancer to neurodegeneration. The antioxidant response element (ARE) signaling pathway plays an important role in the amelioration of oxidative stress. The CellSensor ARE-bla HepG2 cell line (Invitrogen) can be used for analyzing the Nrf2/antioxidant response signaling pathway. Nrf2 (NF-E2-related factor more ..
_
   
 Tested Compounds
 Tested Compounds
All(7341)
 
 
Active(995)
 
 
Inactive(5143)
 
 
Inconclusive(1648)
 
 
 Tested Substances
 Tested Substances
All(9305)
 
 
Active(1147)
 
 
Inactive(6292)
 
 
Inconclusive(1866)
 
 
AID: 743219
Data Source: Tox21 (ARE591)
BioAssay Type: Summary, Candidate Probes/Leads with Supporting Evidence
Depositor Category: Other
BioAssay Version:
Deposit Date: 2013-12-16
Modify Date: 2014-08-21

Data Table ( Complete ):           View Active Data    View All Data
Target
BioActive Compounds: 995
Related Experiments
AIDNameTypeComment
720678qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cellsConfirmatorydepositor-specified cross reference: Blue (460 nm) auto fluorescence counter screen in HEK293 cells
720681qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free cultureConfirmatorydepositor-specified cross reference: Blue (460 nm) auto fluorescence counter screen in HEK293 cell free culture
720685qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free cultureConfirmatorydepositor-specified cross reference: Blue (460 nm) auto fluorescence counter screen in HepG2 cell free culture
720687qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cellsConfirmatorydepositor-specified cross reference: Blue (460 nm) auto fluorescence counter screen in HepG2 cells
743202qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathwayConfirmatorydepositor-specified cross reference: ARE agonist mode screen
743203qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screenConfirmatorydepositor-specified cross reference: Cell viability counter screen
Description:
U.S. Tox21 Program

National Center for Advancing Translational Sciences [NCATS]
NIH Chemical Genomics Center [NCGC]
U.S. Environmental Protection Agency [EPA]
National Institutes of Environmental Health Sciences [NIEHS]
National Toxicology Program [NTP]
U.S. Food and Drug Administration [FDA]

Tox21 Assay Overview:

Oxidative stress has been implicated in the pathogenesis of a variety of diseases ranging from cancer to neurodegeneration. The antioxidant response element (ARE) signaling pathway plays an important role in the amelioration of oxidative stress. The CellSensor ARE-bla HepG2 cell line (Invitrogen) can be used for analyzing the Nrf2/antioxidant response signaling pathway. Nrf2 (NF-E2-related factor 2) and Nrf1 are transcription factors that bind to AREs and activate these genes. The CellSensor ARE-bla Hep G2 cell line contains a beta-lactamase reporter gene under control of the Antioxidant Response Element (ARE) stably integrated into HepG2 cells. The activation of the report gene under culture conditions can be detected by fluorescence intensity. This cell line has been used to screen the Tox21 10K compound library to identify agonists that induce oxidative stress. The cytotoxicity of the Tox21 compound library against the ARE-bla cell line was tested in parallel by measuring the cell viability using CellTiter-Glo assay (Promega, Madison, WI) in the same wells. The compounds were also tested for auto fluorescence that may interfere with the biological target readout resulting in potential false positives and/or negatives.
Protocol
Please refer to other AIDs 743202, 743203, 720687, 720685, 720678 and 720681, for detailed assay protocols.
Comment
This summary is written for the purposes of summarizing the compound activities from the project combining the results from both the ARE agonist mode assay (AID 743202), cell viability counter screen ( 743203), and auto fluorescence counter screens (AIDs 720687, 720685, 720678 and 720681). For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Potency and efficacy were used for determining relative score. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 5 and 30 determined by phenotype.
Disclaimer:
Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).
Result Definitions
Show more
TIDNameDescriptionHistogramTypeUnit
OutcomeThe BioAssay activity outcomeOutcome
ScoreThe BioAssay activity ranking scoreInteger
1Activity SummaryType of compound activity based on both the ARE agonist mode screen and the cell viability and auto fluorescence counter screens.String
2Ratio ActivityType of compound activity in the ratio readout of the ARE agonist mode screen.String
3Ratio Potency (uM)*The concentration of sample yielding half-maximal activation in the ratio readout of the ARE agonist mode screen.FloatμM
4Ratio Efficacy (%)Percent activation in the ratio readout of the ARE agonist mode screen.Float%
5530 nm ActivityType of compound activity in the 530 nm readout of the ARE agonist mode screen.String
6530 nm Potency (uM)The concentration of sample yielding half-maximal activation in the 530 nm readout of the ARE agonist mode screen.FloatμM
7530 nm Efficacy (%)Percent activation in the 530 nm readout of the ARE agonist mode screen.Float%
8460 nm ActivityType of compound activity in the 460 nm readout of the ARE agonist mode screen.String
9460 nm Potency (uM)The concentration of sample yielding half-maximal activation in the 460 nm readout of the ARE agonist mode screen.FloatμM
10460 nm Efficacy (%)Percent activation in the 460 nm readout of the ARE agonist mode screen.Float%
11Viability ActivityType of activity in the cell viability counter screen.String
12Viability Potency (uM)The concentration of sample yielding half-maximal inhibition in the cell viability screen.FloatμM
13Viability Efficacy (%)Percent inhibition in the cell viability counter screen.Float%
14Blue (460 nm) auto fluorescence outcomeType of compound activity in the auto fluorescence counter screens.String
15Sample SourceWhere sample was obtained.String

* Activity Concentration.

Data Table (Concise)
Data Table ( Complete ):     View Active Data    View All Data
PageFrom: